Summary
HSIC Chart
Henry Schein: The Case For An Upgrade From Hold To Buy
Henry Schein is transitioning to higher-margin businesses, with strong tailwinds in dental and medical markets, and is now fairly valued after previous overvaluation. KKR's strategic investment and restructuring support, plus resolution of past issues like the cyber incident, position HSIC for margin improvement and renewed growth. Despite recent stagnation, margin compression, and tariff headwinds, management is actively addressing challenges through efficiency initiatives and product mix shifts.
Henry Schein, Inc. (HSIC) Q2 2025 Earnings Call Transcript
Henry Schein, Inc. (NASDAQ:HSIC ) Q2 2025 Earnings Conference Call August 5, 2025 8:00 AM ET Company Participants Graham Stanley - VP of Investor Relations & Strategic Finance Project Officer Ronald N. South - Senior VP & CFO Stanley M.
Henry Schein (HSIC) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Henry Schein (HSIC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Henry Schein, Inc. (HSIC) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has Henry Schein, Inc. ever had a stock split?
Henry Schein, Inc. Profile
| Medical - Distribution Industry | Healthcare Sector | Stanley M. Bergman CPA CEO | XWBO Exchange | US8064071025 ISIN |
| US Country | 25,000 Employees | - Last Dividend | 8 Feb 2019 Last Split | 3 Nov 1995 IPO Date |
Overview
Henry Schein, Inc. stands as a pivotal provider of healthcare products and services tailored for dental practitioners, laboratories, physician practices, and ambulatory surgery centers. It also extends its offerings to government and institutional health care clinics, and various alternate care clinics globally. Founded in 1932, with its headquarters nestled in Melville, New York, Henry Schein operates through two principal segments: Health Care Distribution, and Technology and Value-Added Services. The company's vast reach and diverse portfolio allow it to be an influential player in promoting wellness and efficiency across the healthcare landscape.
Products and Services
- Health Care Distribution
This segment delivers an extensive range of dental products including essential infection-control products, handpieces, preventatives, and materials for impressions and restorations. It encompasses everything from anesthetics, teeth, and implants, to advanced dental equipment such as chairs, delivery units, lights, and X-ray supplies. Moreover, the division offers pharmaceuticals, vaccines, surgical products, diagnostic tests, and vitamins, catering not just to dental, but also medical needs. Noteworthy is its inclusion of personal protective equipment and services for equipment repair, highlighting its commitment to safety and reliability in healthcare supplies.
- Technology and Value-Added Services
This segment is dedicated to enhancing healthcare practices through innovative software, technology solutions, and supplementary services. It features practice management software systems designed for dental and medical practitioners, aiming to streamline workflows and improve operational efficiency. Further amplifying its value proposition, Henry Schein provides a suite of value-added practice solutions. These encompass consultancy services, education, revenue cycle management, financial services, e-services, and support for practice technology. Also available are network and hardware services, consulting, and continuing education services. This multifaceted approach helps practitioners focus on patient care while optimizing their practice's performance and profitability.
Contact Information
